ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-OR58

Mucin 1 Stimulates TRPM6 Single-Channel Activity and Cell Surface Abundance by Impairing Dynamin-Dependent TRPM6 Endocytosis

Session Information

Category: Fluid, Electrolytes, and Acid-Base Disorders

  • 1101 Fluid, Electrolyte, and Acid-Base Disorders: Basic

Authors

  • Wolf, Matthias Tilmann, University of Michigan Michigan Medicine, Ann Arbor, Michigan, United States
  • Zhang, Jing, The University of Texas Southwestern Medical Center, Dallas, Texas, United States
  • Kozlitina, Julia, The University of Texas Southwestern Medical Center, Dallas, Texas, United States
  • Hoenderop, Joost, Radboud Universitair Medisch Centrum, Nijmegen, Netherlands
  • An, Sung Wan, University of Michigan Michigan Medicine, Ann Arbor, Michigan, United States
Background

Genome-wide association (GWAS) studies revealed an association of Mucin 1 (MUC1) variants with hypomagnesemia. The role of MUC1 in Mg2+ homeostasis remains unclear. Therefore, we evaluated if MUC1 enhances the activity of the Mg2+ channel TRPM6.

Methods

We analyzed the association of MUC1 variants and hypomagnesemia in the Dallas Heart Study (DHS), a cohort containing over 3,500 individuals. In a more focused study, 24 h urine samples of 12 control and 12 calcium-nephrolithiasis patients were analyzed for urinary electrolytes and MUC1 protein content. MUC1 and TRPM6 plasmids were co-expressed in HEK293 cells to investigate the effect of MUC1 on TRPM6 single channel and whole-cell current density by patch-clamp recording. Results were confirmed applying cell surface biotinylation and protein co-immunoprecipitation.

Results

We found that the MUC1 variant rs4072037 associated with hypomagnesemia. Urine samples from control and calcium-nephrolithiasis patients showed significantly lower urinary MUC1 levels and hypermagnesuria in nephrolithiasis patients pointing to a stimulatory role of MUC1 towards Mg2+ absorption. In vitro, co-expression of MUC1 with TRPM6 stimulated TRPM6 single channel current and whole-cell current density. In biotinylation experiments, MUC1 enhanced TRPM6 cell surface abundance. Co-immunoprecipitation confirmed physical interaction between MUC1 and TRPM6. We found that MUC1 interferes with TRPM6 endocytosis by examining the effect of dominant-negative dynamin and dynasore with co-transfected MUC1 and TRPM6. We tested TRPM6 endocytosis more specifically by knocking down clathrin heavy chain or caveolin-1 applying siRNA. Knockdown of both proteins abolished the stimulation of TRPM6 by MUC1. Furthermore, the N-glycan mutant TRPM6 (N787A) was not activated by MUC1. Finally, knockdown of the endogenous urinary lectins Galectin-1 and Galectin-3 also impaired MUC1 activation of TRPM6.

Conclusion

The MUC1 variant rs4072037 associates with hypomagnesemia. In vitro, MUC1 stimulates TRPM6 single channel activity, TRPM6 whole-cell current density and TRPM6 cell surface abundance by impairing dynamin-dependent TRPM6 endocytosis. TRPM6 and MUC1 physically interact and form lattice with the TRPM6 N-glycan N787. Urinary Galectin-1 and Galectin-3 stabilize this complex.

Funding

  • Other U.S. Government Support